The Effects of Continuous Positive Airway Pressure on Overlap Syndrome
Launched by CHANG GUNG MEMORIAL HOSPITAL · Jun 3, 2009
Trial Information
Current as of August 29, 2025
Completed
Keywords
ClinConnect Summary
COPD patients will be disturbed by season 12 months follow up is better than 18 months
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • chronic stable COPD
- • FEV1/FVC \< 70%
- • No response to beta-agonist
- • without acute exacerbation within2 months
- Exclusion Criteria:
- • Chronic respiratory failure (PaO2\<60 mmHg, PaCO2\>50 mmHg)
- • Clinical evidence of congestive heart failure
- • Facial defect and all the other condition that can't tolerate nasal mask
- • Malignancy
About Chang Gung Memorial Hospital
Chang Gung Memorial Hospital, one of the largest healthcare organizations in Taiwan, is renowned for its commitment to advancing medical research and improving patient care. As a clinical trial sponsor, the hospital leverages its extensive clinical expertise and state-of-the-art facilities to conduct innovative research across various medical disciplines. With a focus on collaboration and ethical practices, Chang Gung Memorial Hospital aims to contribute to the global body of medical knowledge through rigorous clinical trials that enhance treatment options and improve health outcomes for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Trial Officials
Yu-Lun Lo, MD
Study Director
Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan
Tsai-Yu Wang, MD
Principal Investigator
Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan
Han-Pin Kuo, MD,PHD
Study Chair
Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taipei, Taiwan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials